
doi: 10.22546/60/2113
Enoxaparina es un fármaco utilizado en la prevención y tratamiento de la enfermedad tromboembólica venosa. Las manifestaciones dermatológicas observadas por este fármaco acontecen principalmente en el lugar de la inyección en forma de hematomas, equimosis, necrosis cutánea, dermatosis de contacto o urticaria, no obstante aunque entre las manifestaciones cutáneas frecuentes destaca la urticaria, prurito y eritema hemos de conocer otras poco frecuentes como es la dermatosis bullosa hemorrágica a distancia inducida por heparina.
enoxaparina, dermatosis hemorragica, R, Medicine, Internal medicine, RC31-1245, heparina bajo peso molecular
enoxaparina, dermatosis hemorragica, R, Medicine, Internal medicine, RC31-1245, heparina bajo peso molecular
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
